Literatur
Bergqvist D, Comerota AJ, Nicolaides AN, Scurr JH (1994) Prevention of venous thromboembolism. Med Orion, London
Bertina RM, Koeleman BP, Koster T et al. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:46–47
Boneu B (1994) Low molecular weight heparin therapy: is monitoring needed? Thromb Haemost 72:330–334
Bounameaux H (1994) Low-molecularweight-heparins in prophylaxis and therapy of thromboembolic diseases. Marcel Dekker, New York
Cogo A, Bernardi E, Prandoni P, ιrolami B, Noventa F, Simioni P, Girolami A (1994) Acquired risk factors for deep-vein thrombosis in symptomatic outpatients. Arch Intern Med 154:164–168
Consensus Conference NIH (1986) Prevention of venous thrombosis and pumonary embolism. JAMA 256:744–757
Dahlbäck B (1994) Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene. Haemostasis 24:139–151
Diehm C, Stammler F, Amendt K (1997) Die tiefe Venenthrombose. Diagnostik und Therapie. Dtsch Aerztebl 94:A301–311
Elder DM, Greer KE (1995) Venous disease: how to heal and prevent chronic leg ulcers. Geriatrics 50:30–36
European Consensus Statement (1992) Prevention of venous thromboembolism. Int Angiol 11:151–159
Gaylarde PM, Sarkany I, Dodd HJ (1993) The effect of compression on venous stasis. Br J Dermatol 128:255–258
Gibson GE, Su WP, Pittelkow MR (1997) Antiphosphlipid syndrome and the skin. J Am Acad Dermatol 36:970–982
Gupta AK, Kovacs MJ, Sauder DN (1998) Heparin-induced thrombocytopenia. Ann Pharmacother 32:55–59
Jeffrey PC, Nicolaides AN (1990) Graduated compression stockings in the prevention of postoperative deep vein thrombosis. Br J Surg 77:380–383
Lagerstedt C, Olsson CG, Fagher B, Norgren L, Tengborn L (1993) Recurrence and late sequelae after first-time deep vein thrombosis: relationship to initial signs. Phebology 8:62–67
Milne AA, Ruckley CV (1994) The clinical course of patients following extensive deep venous thrombosis. Eur J Vasc Surg 5:56–59
Monreal M, Casals A, Boix J, Olazabal A, Monserrat E, Mundo MR (1993) Occult cancer in patients with deep venous thrombosis. A systematic approach. Cancer 67:541–545
Mostbeck A, Partsch H, Köhn H (1983) Altersverteilung und Häufigkeit venöser Thromboembolien. In: Piza F, Marosi L (Hrsg) Angiologie und Geriatrie. Robidruck, Wien, pp 375–376
Partsch H (1991) Compression therapy of the legs. J Dermatol Surg Oncol 17:799–805
Partsch H (1996) Diagnose und Therapie der tiefen Venenthrombose. VASA [Suppl] 46:1–53
Partsch H, Blättler W (1996) Leitlinien zur Thromboembolie-Prophylaxe. Phlebologie 25:261–266
Partsch H, Blättler W (2000) Leitlinie zur Thromboembolie-Prophylaxe. Phlebologie 29:106ff
Petres J, Rompel R (1994) Stellenwert der operativen Dermatologie in Klinik und Praxis. Hautarzt 45:133–139
Petres J, Rompel R (1996) Operative Dermatologie.Lehrbuch und Atlas. Springer, Berlin Heidelberg New York Tokyo
Rompel R, Petres J (1999) Operative onkologische Dermatologie. Fortschritte der operativen Dermatologie — Bd 15. Springer, Berlin Heidelberg New York Tokyo
Scurr JH (1990) How long after surgery does the risk of thromboembolism persist? Acta Chir Scand 556:22–24
Walker ID (1997) Congenital thrombophilia. Baillieres Clin Obstet Gynaecol 11:431–445
Wulf H (1995) Thromboembolieprophylaxe und rückenmarksnahe Regionalanästhesie. Anästh Intensivmed 36:216–217
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rompel, R., Rabe, E., Hackert, I. et al. Spezielle Aspekte zur Thromboembolieprophylaxe in der operativen Dermatologie. Hautarzt 53, 179–182 (2002). https://doi.org/10.1007/s001050100247
Published:
Issue Date:
DOI: https://doi.org/10.1007/s001050100247